ADIL Historical PE Ratio image   This ADIL PE ratio history page last updated 5/18/2022
ADIL Historical PE Ratio Chart
Data adjusted for ADIL split history

PeriodPriceGAAPAnnualizedPE
Q1 2022
5/16/2022
1.42-0.13-0.52NA
Q4 2021
3/28/2022
1.97-0.28-1.12NA
Q3 2021
11/15/2021
3.16-0.22-0.88NA
Q2 2021
8/12/2021
3.10-0.25-1.00NA
Q1 2021
5/17/2021
2.29-0.30-1.20NA
Q4 2020
3/22/2021
2.51-0.24-0.96NA
Q3 2020
11/13/2020
1.84-0.24-0.96NA
Q2 2020
8/13/2020
1.63-0.16-0.64NA
Q1 2020
5/14/2020
1.36-0.22-0.88NA
Q4 2019
3/20/2020
1.20-0.19-0.76NA
Q3 2019
11/14/2019
1.58-0.17-0.68NA
Q2 2019
8/13/2019
1.72-0.21-0.84NA
Q1 2019
5/15/2019
2.28-0.33-1.32NA
Q4 2018
2/14/2019
4.30-0.26-1.04NA
Q3 2018
11/14/2018
1.21-1.48-5.92NA
ADIL PE History Chart
PeriodPriceGAAPTTMPE
Q1 2022
5/16/2022
1.42-0.13-0.88NA
Q4 2021
3/28/2022
1.97-0.28-1.05NA
Q3 2021
11/15/2021
3.16-0.22-1.01NA
Q2 2021
8/12/2021
3.10-0.25-1.03NA
Q1 2021
5/17/2021
2.29-0.30-0.94NA
Q4 2020
3/22/2021
2.51-0.24-0.86NA
Q3 2020
11/13/2020
1.84-0.24-0.81NA
Q2 2020
8/13/2020
1.63-0.16-0.74NA
Q1 2020
5/14/2020
1.36-0.22-0.79NA
Q4 2019
3/20/2020
1.20-0.19-0.90NA
Q3 2019
11/14/2019
1.58-0.17-0.97NA
Q2 2019
8/13/2019
1.72-0.21-2.28NA
Q1 2019
5/15/2019
2.28-0.33NANA
Q4 2018
2/14/2019
4.30-0.26NANA
Q3 2018
11/14/2018
1.21-1.48NANA
Quotes delayed 20 minutes

Email EnvelopeFree ADIL Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Adial Pharmaceuticals (ADIL) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

ADMA PE Ratio History
ADMP PE Ratio History
ADMS PE Ratio History
ADPT PE Ratio History
ADTX PE Ratio History
ADUS PE Ratio History
ADVM PE Ratio History
ADXS PE Ratio History
AEMD PE Ratio History
AERI PE Ratio History
How should the ADIL historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Adial Pharmaceuticals. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this ADIL Historical PE Ratio page.

What is the average historical PE for ADIL based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The ADIL historical PE ratio using the annualized quarterly earnings method works out to NA.

What is the average historical PE for ADIL based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The ADIL historical PE ratio using the TTM earnings method works out to NA.

On this page we presented the ADIL Historical PE Ratio information for Adial Pharmaceuticals' stock. The average ADIL historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is NA. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average ADIL historical PE based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this ADIL historical PE result, against the recent PE: when this page was posted on 5/17/2022, the most recent closing price for ADIL had been 1.48, and the most recent quarterly earnings result, annualized, was NA. Meanwhile, the most recent TTM earnings summed to NA.

For self directed investors doing their due diligence on ADIL or any other given stock, valuation analysis for ADIL can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Adial Pharmaceuticals PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for ADIL. Thanks for visiting, and the next time you need to research ADIL Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: Top Ten Hedge Funds Holding SICK, WF market cap history, Top Ten Hedge Funds Holding JMIN.

 

ADIL Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.